At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Dexmedetomidine on Postoperative Glucose Levels and Insulin Secretion Patterns in Obese Patients With Impaired Glucose Tolerance.
In Brief
A Phase 4 clinical trial evaluating Dexmedetomidine, 0.9% Sodium-chloride, and 2 other interventions for Bariatric Surgery Candidate and 2 related conditions. Completed, enrolled 40 participants.
Detailed Summary
This study investigated the effect of dexmedetomidine in obese patients undergoing bariatric surgery.
Study Details
Timeline
Interventions
A bolus of 1ug/kg in 10 minutes, followed by an infusion of 0.5ug/kg/h until the end of surgery.
The same infusion rate used in the dexmedetomidine group.
Intraoperative fentanyl was given in case of 25% increment in the blood pressure and/or heart rate in comparison to baseline (previous anesthesia induction).
Boluses of 3mg of intravenous morphine were given in the postoperative acute care unit. Once the pain score was equal or less than 3/10 the patient-controlled analgesia pumps were installed and the patients were discharged to their room.